APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Suicide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-Suicide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchAnti-Suicide Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Suicide Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Anti-Suicide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Suicide Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Suicide Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anti-Suicide Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-Suicide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Suicide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Suicide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-Suicide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Suicide Drugs include Pfizer, Inc, AstraZeneca Plc, Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc, H. Lundbeck A/S, NeuroRx, Inc and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Suicide Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Suicide Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Suicide Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Suicide Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Suicide Drugs Segment by Company

Pfizer, Inc

AstraZeneca Plc

Eli Lilly and Company

Allergan Plc

GlaxoSmithKline Plc

Merck & Co., Inc

H. Lundbeck A/S

NeuroRx, Inc

Johnson & Johnson

Janssen Pharmaceutical Ltd

Anti-Suicide Drugs Segment by Type

Anti-Depressants and Anti-Anxiety Drugs

Anti-Psychotic Drugs

NMDA Antagonist

Antibiotic Analog

Anti-Suicide Drugs Segment by Application

Hospitals

Retail Pharmacies

Online Pharmacies

Anti-Suicide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Suicide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Suicide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Suicide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Suicide Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Suicide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-Suicide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-Suicide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-Suicide Drugs Industry Trends Table 2. Anti-Suicide Drugs Industry Drivers Table 3. Anti-Suicide Drugs Industry Opportunities and Challenges Table 4. Anti-Suicide Drugs Industry Restraints Table 5. Global Anti-Suicide Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-Suicide Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-Suicide Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Anti-Suicide Drugs Sales Market Share by Manufacturers Table 9. Global Anti-Suicide Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Anti-Suicide Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-Suicide Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-Suicide Drugs Manufacturers, Product Type & Application Table 13. Global Anti-Suicide Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Suicide Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anti-Depressants and Anti-Anxiety Drugs Table 17. Major Manufacturers of Anti-Psychotic Drugs Table 18. Major Manufacturers of NMDA Antagonist Table 19. Major Manufacturers of Antibiotic Analog Table 20. Global Anti-Suicide Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Anti-Suicide Drugs Sales by Type (2021-2026) & (k units) Table 22. Global Anti-Suicide Drugs Sales by Type (2027-2032) & (k units) Table 23. Global Anti-Suicide Drugs Sales Market Share by Type (2021-2026) Table 24. Global Anti-Suicide Drugs Sales Market Share by Type (2027-2032) Table 25. Global Anti-Suicide Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Anti-Suicide Drugs Revenue by Type (2021-2026) & (k units) Table 27. Global Anti-Suicide Drugs Revenue by Type (2027-2032) & (k units) Table 28. Global Anti-Suicide Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Anti-Suicide Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Retail Pharmacies Table 32. Major Manufacturers of Online Pharmacies Table 33. Global Anti-Suicide Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Anti-Suicide Drugs Sales by Application (2021-2026) & (k units) Table 35. Global Anti-Suicide Drugs Sales by Application (2027-2032) & (k units) Table 36. Global Anti-Suicide Drugs Sales Market Share by Application (2021-2026) Table 37. Global Anti-Suicide Drugs Sales Market Share by Application (2027-2032) Table 38. Global Anti-Suicide Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Anti-Suicide Drugs Revenue by Application (2021-2026) & (k units) Table 40. Global Anti-Suicide Drugs Revenue by Application (2027-2032) & (k units) Table 41. Global Anti-Suicide Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Anti-Suicide Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Anti-Suicide Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Anti-Suicide Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Anti-Suicide Drugs Sales Market Share by Region (2021-2026) Table 46. Global Anti-Suicide Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Anti-Suicide Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Anti-Suicide Drugs Sales by Country (2021-2026) & (k units) Table 50. North America Anti-Suicide Drugs Sales by Country (2027-2032) & (k units) Table 51. Europe Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Anti-Suicide Drugs Sales by Country (2021-2026) & (k units) Table 53. Europe Anti-Suicide Drugs Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Anti-Suicide Drugs Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Anti-Suicide Drugs Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Anti-Suicide Drugs Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Anti-Suicide Drugs Sales by Country (2027-2032) & (k units) Table 60. Global Anti-Suicide Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Anti-Suicide Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Anti-Suicide Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Anti-Suicide Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Anti-Suicide Drugs Revenue Market Share by Region (2027-2032) Table 65. Pfizer, Inc Company Information Table 66. Pfizer, Inc Business Overview Table 67. Pfizer, Inc Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Pfizer, Inc Anti-Suicide Drugs Product Portfolio Table 69. Pfizer, Inc Recent Development Table 70. AstraZeneca Plc Company Information Table 71. AstraZeneca Plc Business Overview Table 72. AstraZeneca Plc Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AstraZeneca Plc Anti-Suicide Drugs Product Portfolio Table 74. AstraZeneca Plc Recent Development Table 75. Eli Lilly and Company Company Information Table 76. Eli Lilly and Company Business Overview Table 77. Eli Lilly and Company Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eli Lilly and Company Anti-Suicide Drugs Product Portfolio Table 79. Eli Lilly and Company Recent Development Table 80. Allergan Plc Company Information Table 81. Allergan Plc Business Overview Table 82. Allergan Plc Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Allergan Plc Anti-Suicide Drugs Product Portfolio Table 84. Allergan Plc Recent Development Table 85. GlaxoSmithKline Plc Company Information Table 86. GlaxoSmithKline Plc Business Overview Table 87. GlaxoSmithKline Plc Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. GlaxoSmithKline Plc Anti-Suicide Drugs Product Portfolio Table 89. GlaxoSmithKline Plc Recent Development Table 90. Merck & Co., Inc Company Information Table 91. Merck & Co., Inc Business Overview Table 92. Merck & Co., Inc Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Merck & Co., Inc Anti-Suicide Drugs Product Portfolio Table 94. Merck & Co., Inc Recent Development Table 95. H. Lundbeck A/S Company Information Table 96. H. Lundbeck A/S Business Overview Table 97. H. Lundbeck A/S Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. H. Lundbeck A/S Anti-Suicide Drugs Product Portfolio Table 99. H. Lundbeck A/S Recent Development Table 100. NeuroRx, Inc Company Information Table 101. NeuroRx, Inc Business Overview Table 102. NeuroRx, Inc Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. NeuroRx, Inc Anti-Suicide Drugs Product Portfolio Table 104. NeuroRx, Inc Recent Development Table 105. Johnson & Johnson Company Information Table 106. Johnson & Johnson Business Overview Table 107. Johnson & Johnson Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Johnson & Johnson Anti-Suicide Drugs Product Portfolio Table 109. Johnson & Johnson Recent Development Table 110. Janssen Pharmaceutical Ltd Company Information Table 111. Janssen Pharmaceutical Ltd Business Overview Table 112. Janssen Pharmaceutical Ltd Anti-Suicide Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Janssen Pharmaceutical Ltd Anti-Suicide Drugs Product Portfolio Table 114. Janssen Pharmaceutical Ltd Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Anti-Suicide Drugs Distributors List Table 118. Anti-Suicide Drugs Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Anti-Suicide Drugs Product Image Figure 2. Global Anti-Suicide Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Suicide Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Suicide Drugs Sales (2021-2032) & (k units) Figure 5. Global Anti-Suicide Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-Suicide Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anti-Depressants and Anti-Anxiety Drugs Image Figure 9. Anti-Psychotic Drugs Image Figure 10. NMDA Antagonist Image Figure 11. Antibiotic Analog Image Figure 12. Global Anti-Suicide Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Anti-Suicide Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Anti-Suicide Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Anti-Suicide Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Anti-Suicide Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Anti-Suicide Drugs Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Retail Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Global Anti-Suicide Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Anti-Suicide Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-Suicide Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Anti-Suicide Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Anti-Suicide Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Anti-Suicide Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Anti-Suicide Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Anti-Suicide Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Anti-Suicide Drugs Sales Market Share by Country (2021-2032) Figure 41. China Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Anti-Suicide Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Anti-Suicide Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Anti-Suicide Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Anti-Suicide Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Anti-Suicide Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Anti-Suicide Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Anti-Suicide Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Anti-Suicide Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti-Suicide Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Anti-Suicide Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Depressants and Anti-Anxiety Drugs
  • Anti-Psychotic Drugs
  • NMDA Antagonist
  • Antibiotic Analog
Applications
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
Companies covered
  • Pfizer, Inc
  • AstraZeneca Plc
  • Eli Lilly and Company
  • Allergan Plc
  • GlaxoSmithKline Plc
  • Merck & Co., Inc
  • H. Lundbeck A/S
  • NeuroRx, Inc
  • Johnson & Johnson
  • Janssen Pharmaceutical Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Suicide Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Suicide Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-Suicide Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-Suicide Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-Suicide Drugs Market Dynamics
  1. 2.1 Anti-Suicide Drugs Industry Trends
  2. 2.2 Anti-Suicide Drugs Industry Drivers
  3. 2.3 Anti-Suicide Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-Suicide Drugs Industry Restraints
3 Anti-Suicide Drugs Market by Manufacturers
  1. 3.1 Global Anti-Suicide Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-Suicide Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-Suicide Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-Suicide Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Suicide Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-Suicide Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Anti-Suicide Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Suicide Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Suicide Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Suicide Drugs Tier 1, Tier 2, and Tier 3
4 Anti-Suicide Drugs Market by Type
  1. 4.1 Anti-Suicide Drugs Type Introduction
  2. 4.1.1 Anti-Depressants and Anti-Anxiety Drugs
  3. 4.1.2 Anti-Psychotic Drugs
  4. 4.1.3 NMDA Antagonist
  5. 4.1.4 Antibiotic Analog
  6. 4.2 Global Anti-Suicide Drugs Sales by Type
  7. 4.2.1 Global Anti-Suicide Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anti-Suicide Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Anti-Suicide Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Anti-Suicide Drugs Revenue by Type
  11. 4.3.1 Global Anti-Suicide Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anti-Suicide Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Anti-Suicide Drugs Revenue Market Share by Type (2021-2032)
5 Anti-Suicide Drugs Market by Application
  1. 5.1 Anti-Suicide Drugs Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Anti-Suicide Drugs Sales by Application
  6. 5.2.1 Global Anti-Suicide Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Suicide Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Anti-Suicide Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Anti-Suicide Drugs Revenue by Application
  10. 5.3.1 Global Anti-Suicide Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anti-Suicide Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Anti-Suicide Drugs Revenue Market Share by Application (2021-2032)
6 Global Anti-Suicide Drugs Sales by Region
  1. 6.1 Global Anti-Suicide Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Suicide Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Suicide Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-Suicide Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-Suicide Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-Suicide Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-Suicide Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-Suicide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-Suicide Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-Suicide Drugs Revenue by Region
  1. 7.1 Global Anti-Suicide Drugs Revenue by Region
  2. 7.1.1 Global Anti-Suicide Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-Suicide Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-Suicide Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-Suicide Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-Suicide Drugs Revenue (2021-2032)
  8. 7.2.2 North America Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-Suicide Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-Suicide Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-Suicide Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-Suicide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer, Inc
  2. 8.1.1 Pfizer, Inc Company Information
  3. 8.1.2 Pfizer, Inc Business Overview
  4. 8.1.3 Pfizer, Inc Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer, Inc Anti-Suicide Drugs Product Portfolio
  6. 8.1.5 Pfizer, Inc Recent Developments
  7. 8.2 AstraZeneca Plc
  8. 8.2.1 AstraZeneca Plc Company Information
  9. 8.2.2 AstraZeneca Plc Business Overview
  10. 8.2.3 AstraZeneca Plc Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Plc Anti-Suicide Drugs Product Portfolio
  12. 8.2.5 AstraZeneca Plc Recent Developments
  13. 8.3 Eli Lilly and Company
  14. 8.3.1 Eli Lilly and Company Company Information
  15. 8.3.2 Eli Lilly and Company Business Overview
  16. 8.3.3 Eli Lilly and Company Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company Anti-Suicide Drugs Product Portfolio
  18. 8.3.5 Eli Lilly and Company Recent Developments
  19. 8.4 Allergan Plc
  20. 8.4.1 Allergan Plc Company Information
  21. 8.4.2 Allergan Plc Business Overview
  22. 8.4.3 Allergan Plc Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Allergan Plc Anti-Suicide Drugs Product Portfolio
  24. 8.4.5 Allergan Plc Recent Developments
  25. 8.5 GlaxoSmithKline Plc
  26. 8.5.1 GlaxoSmithKline Plc Company Information
  27. 8.5.2 GlaxoSmithKline Plc Business Overview
  28. 8.5.3 GlaxoSmithKline Plc Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Plc Anti-Suicide Drugs Product Portfolio
  30. 8.5.5 GlaxoSmithKline Plc Recent Developments
  31. 8.6 Merck & Co., Inc
  32. 8.6.1 Merck & Co., Inc Company Information
  33. 8.6.2 Merck & Co., Inc Business Overview
  34. 8.6.3 Merck & Co., Inc Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck & Co., Inc Anti-Suicide Drugs Product Portfolio
  36. 8.6.5 Merck & Co., Inc Recent Developments
  37. 8.7 H. Lundbeck A/S
  38. 8.7.1 H. Lundbeck A/S Company Information
  39. 8.7.2 H. Lundbeck A/S Business Overview
  40. 8.7.3 H. Lundbeck A/S Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 H. Lundbeck A/S Anti-Suicide Drugs Product Portfolio
  42. 8.7.5 H. Lundbeck A/S Recent Developments
  43. 8.8 NeuroRx, Inc
  44. 8.8.1 NeuroRx, Inc Company Information
  45. 8.8.2 NeuroRx, Inc Business Overview
  46. 8.8.3 NeuroRx, Inc Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NeuroRx, Inc Anti-Suicide Drugs Product Portfolio
  48. 8.8.5 NeuroRx, Inc Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Anti-Suicide Drugs Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Janssen Pharmaceutical Ltd
  56. 8.10.1 Janssen Pharmaceutical Ltd Company Information
  57. 8.10.2 Janssen Pharmaceutical Ltd Business Overview
  58. 8.10.3 Janssen Pharmaceutical Ltd Anti-Suicide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Janssen Pharmaceutical Ltd Anti-Suicide Drugs Product Portfolio
  60. 8.10.5 Janssen Pharmaceutical Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Suicide Drugs Value Chain Analysis
  2. 9.1.1 Anti-Suicide Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Suicide Drugs Production Mode & Process
  6. 9.2 Anti-Suicide Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Suicide Drugs Distributors
  9. 9.2.3 Anti-Suicide Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst